Rex Bionics Plc (the Company) was formally the owner of the “Rex Business” that pioneered the REX Technology, a robotic walking device for use by people with a significant neurological injury or illness.
On 25 May 2017 the Company completed a major restructuring in which ownership of the entire Rex Business was transferred to the company’s Australian subsidiary Rex Bionics Pty Ltd, which in parallel received funding from investment funds based in Australia.
The continued development and commercialisation of the REX technology is now being undertaken by Rex Bionics Pty Ltd. The Company retains a significant minority shareholding in Rex Bionics Pty Ltd and is represented on its board of directors.
Further details of the May 2017 restructuring are available in the company’s circular to shareholders dated 4 May 2017, which can be accessed via the investors page.
For more information on the continuing Rex Business, please click on the following link: www.rexbionics.com